Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two drugs (nelfinavir [NFV] and efavirenz [EFV]) used
in start-up anti-HIV treatment. Doctors want to see if one is better than the other in
extending the time that viral load (level of HIV in the blood) is kept low. The study will
also look at the response of the immune system to each drug.